The make DEEP Human Families Blog

Posts

June 02, 2026

New diabetes clinical trial: tSCS and AR Training on QoL and Physical Activity in Diabetic Neuropathy Patients

Published on: 2026-06-02T04:00:00Z Conditions : Diabetic Neuropathy Interventions : Other: Transcutaneous spinal cord stimulation Group; Other: Augmented reality Sponsors : Riphah International University Not yet recruiting https://ift.tt/dFW1t6o

Search This Blog

The make DEEP Human Families Blog

Posts

UI Health Collaborations and Education

Helping the Crippled 2 God

The Temple of TRANCE Health Portal

TRANCEatable by Pharmakon Health Cloud

Emergent APHID Helpful Resources

Make DEEP Humans a Divided Line

Computational Arrays and Objects for Scientific and Med Lab Research Featured Post

New diabetes clinical trial: tSCS and AR Training on QoL and Physical Activity in Diabetic Neuropathy Patients

Latest Posts

New diabetes clinical trial: HRX215, A First Generation MKK4 Inhibitor Drug, for the Treatment of Patients With Colorectal Liver Metastasis After Undergoing a Portal Vein Embolization

New diabetes clinical trial: Clinical, Oncologic, and Metabolic Effects of Pancreatic Mass Loss After Pancreatectomy in Non-Diabetic Patients

New diabetes clinical trial: A Study of Orforglipron (LY3502970) in Participants With Type 2 Diabetes Who Observe Ramadan Fasting

New diabetes clinical trial: AI-Based Risk Prediction Model for Upper Digestive Tract Cancer

New diabetes clinical trial: Clinical Information System Impact on Hospitalized Patients With Chronic Disease

New diabetes clinical trial: CGM Experience, Preferences & Blood Glucose Parameters

New diabetes clinical trial: Triglyceride-rich LIPoproteins and INflammatory Cytokines After Oral FAT Loading as Potential Early Biomarkers of the Risk of Progression Towards DIABETES and Development of Complications. LIPINFAT Diabetes Study.

New diabetes clinical trial: Oral Health and Systemic Diseases: Survey of General Practitioners

New diabetes clinical trial: Efficacy, Safety, and Tolerability of Tirzepatide in Real-World Conditions in Paraguay.

New diabetes clinical trial: MEDBRIDGE-Guided NCM/CHW Post-Discharge Support for High-Risk T2D Patients